{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-25-000131","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2025-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.159141+00:00","generated_at":"2026-05-17T05:39:41.278718+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"BioRestorative Therapies shareholders elect directors, approve stock plan amendment, ratify auditor, okay exec pay","bullets":["Elected Francisco Silva (1.59M for) and David Rosa (1.47M for) as Class II directors; ~3.33M broker non-votes.","Approved amendment to 2021 Stock Incentive Plan boosting authorized shares from 6.85M to 9.85M (1.34M for, 289K against).","Ratified CBIZ CPAs as independent auditor for FY2025: 4.72M for, 271K against, 4,864 abstentions.","Advisory vote on executive compensation passed: 1.54M for, 107K against, 19,855 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-25-000131","json":"https://secwatch.observer/filing/0001021771-25-000131.json","markdown":"https://secwatch.observer/filing/0001021771-25-000131.md","text":"https://secwatch.observer/filing/0001021771-25-000131.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000131/0001021771-25-000131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000131/brt91825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:39:41.278718+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}